Buy or sell TeselaGen stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

TeselaGen Stock

TeselaGen is accelerating the design and fabrication of DNA with synthetic biology software.

About TeselaGen Stock

TeselaGen is building a rapid prototyping system for fast bio-based construction of sustainably sourced chemicals, therapeutic medicines, and novel vaccines. Their customers are biopharmaceutical and bioindustrial companies like Amgen and Genomatica. Their bioCAD/CAM system is based on technology exclusively licensed from Lawrence Berkeley National Lab and is being beta tested by hundreds of users.


Founder and Chief Scientific Officer

Nathan Hillson

Founder & CEO

Michael Fero

Founder & CTO

Eduardo Abeliuk

Team Member

Nick Elsbree


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from TeselaGen or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 250K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: